Hyperimmunoglobulin therapy for a twin fetus with cytomegalovirus infection and growth restriction

Article Abstract:

Immunoglobulin therapy may be effective in treating cytomegalovirus infection in fetuses. Doctors used this treatment on a woman pregnant with twins who contracted cytomegalovirus infection while she was pregnant. Ultrasound scans showed that one of the twins had stopped growing. She was given cytomegalovirus-specific immunoglobulin intravenously for three days and immunoglobulin was also injected into the amniotic sac of the affected fetus. A few weeks later, this twin began growing again. About nine months after birth, both twins consistently tested negative for cytomegalovirus.

Immunoglobulins

---

Passive immunization during pregnancy for congenital cytomegalovirus infection

Article Abstract:

Pregnant women are treated for a primary cytomegalovirus (CMV) infection with intravenous CMV hyperimmune globulin. The method of treatment is found to be safe and it may be successful in treating and preventing congenital CMV infection in pregnant women.

United Kingdom

---

Passive immunization during pregnancy for congenital cytomegalovirus infection

Article Abstract:

Pregnant women are treated for a primary cytomegalovirus (CMV) infection with intravenous CMV hyperimmune globulin. The method of treatment is found to be safe and it may be successful in treating and preventing congenital CMV infection in pregnant women.

United States, Diagnosis, Risk factors, Pregnancy, Complications of, Pregnancy complications

Similar abstracts:

• Abstracts: The preterm prediction study: significance of vaginal infections. Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment
• Abstracts: Costimulation blockade with belatacept in renal transplantation. Immunosuppressive drugs for kidney transplantation
• Abstracts: Protective conditioning for acute graft-versus-host disease. Tolerance and chimerism after renal and hematopoietic-cell transplantation
• Abstracts: Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. Intensive insulin therapy and pentastarch resuscitation in severe sepsis
• Abstracts: Long-term vasodilator therapy in patients with severe aortic regurgitation. Long-term follow-up of idiopathic chronic pericardial effusion

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.